Anticoagulant effects of hirulog, ∗∗Hirulog™ brand direct thrombin inhibitor. a novel thrombin inhibitor, in patients with coronary artery disease

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Thienkhai Vu, David T. Hung, V I Wheaton et al. · Cell · 1991 · 3K citations

Life Sciences, Biochemistry, Molecular Biology +14

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Manual of pharmacologic calculations with computer programs

International Journal of Biochemistry · 1988 · 1.5K citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +12

Aspirin, Heparin, or Both to Treat Acute Unstable Angina

Pierre Théroux, Hélène Ouimet, John McCans et al. · New England Journal of Medicine · 1988 · 1.3K citations

Medicine, Cardiology, Pharmacotherapy +13

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Jeffrey I. Weitz, Monika Hudoba, David Massel et al. · Journal of Clinical Investigation · 1990 · 1.1K citations · Full text

Medicine, Cardiology, Pharmacology +16